Dual Myostatin and Dystrophin Exon Skipping by Morpholino Nucleic Acid Oligomers Conjugated to a Cell-penetrating Peptide Is a Promising Therapeutic Strategy for the Treatment of Duchenne Muscular Dystrophy. (2012)
Attributed to:
Antisense nucleic acid splice correction therapy for Duchenne muscular dystrophy and related disorders
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/mtna.2012.54
PubMed Identifier: 23250360
Publication URI: http://europepmc.org/abstract/MED/23250360
Type: Journal Article/Review
Volume: 1
Parent Publication: Molecular therapy. Nucleic acids
ISSN: 2162-2531